Better Therapeutics (BTTX) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesOptions ChainSEC FilingsShort InterestTrendsBuy This Stock BTTX vs. UPHL, OPGN, ACONW, AONC, DHACW, FMS, LFMDP, OTRKP, PIIIW, and TALKWShould you be buying Better Therapeutics stock or one of its competitors? The main competitors of Better Therapeutics include UpHealth (UPHL), OpGen (OPGN), Aclarion (ACONW), American Oncology Network (AONC), Digital Health Acquisition (DHACW), Fresenius Medical Care AG & Co. KGaA (FMS), LifeMD (LFMDP), Ontrak (OTRKP), P3 Health Partners (PIIIW), and Talkspace (TALKW). These companies are all part of the "healthcare" industry. Better Therapeutics vs. Its Competitors UpHealth OpGen Aclarion American Oncology Network Digital Health Acquisition Fresenius Medical Care AG & Co. KGaA LifeMD Ontrak P3 Health Partners Talkspace Better Therapeutics (NASDAQ:BTTX) and UpHealth (NYSE:UPHL) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, media sentiment, valuation, risk, earnings, dividends, analyst recommendations and institutional ownership. Which has more risk & volatility, BTTX or UPHL? Better Therapeutics has a beta of 0.97, meaning that its stock price is 3% less volatile than the S&P 500. Comparatively, UpHealth has a beta of 0.83, meaning that its stock price is 17% less volatile than the S&P 500. Is BTTX or UPHL more profitable? Company Net Margins Return on Equity Return on Assets Better TherapeuticsN/A N/A N/A UpHealth N/A N/A N/A Does the media refer more to BTTX or UPHL? In the previous week, Better Therapeutics' average media sentiment score of 0.00 equaled UpHealth'saverage media sentiment score. Company Overall Sentiment Better Therapeutics Neutral UpHealth Neutral Do institutionals & insiders have more ownership in BTTX or UPHL? 34.0% of Better Therapeutics shares are owned by institutional investors. Comparatively, 56.1% of UpHealth shares are owned by institutional investors. 51.4% of Better Therapeutics shares are owned by insiders. Comparatively, 34.2% of UpHealth shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Which has stronger valuation & earnings, BTTX or UPHL? Better Therapeutics has higher earnings, but lower revenue than UpHealth. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBetter TherapeuticsN/AN/A-$39.76MN/AN/AUpHealth$130M0.00-$56.42M-$1.350.00 SummaryBetter Therapeutics beats UpHealth on 3 of the 5 factors compared between the two stocks. Get Better Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for BTTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BTTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BTTX vs. The Competition Export to ExcelMetricBetter TherapeuticsHealth services IndustryMedical SectorNASDAQ ExchangeMarket Cap$5K$76.68M$5.75B$10.27BDividend YieldN/AN/A5.72%4.60%P/E RatioN/AN/A74.9226.41Price / SalesN/A3.05457.0188.61Price / CashN/A4.0225.8129.91Price / BookN/A1.1513.256.28Net Income-$39.76M-$26.33M$3.29B$270.38M Better Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BTTXBetter TherapeuticsN/AN/AN/AN/A$5KN/A0.0040UPHLUpHealthN/A$0.00flatN/A-99.9%$4K$130M0.001,750High Trading VolumeOPGNOpGenN/A$0.00flatN/AN/A$1K$2.67M0.00100Positive NewsShort Interest ↓ACONWAclarionN/A$0.03-14.0%N/A-12.9%$0.00$62.95K0.007Gap UpAONCAmerican Oncology NetworkN/A$10.78-2.0%N/A+201.4%$0.00$1.34B0.001,520News CoverageShort Interest ↑Gap DownDHACWDigital Health AcquisitionN/A$0.03-2.2%N/AN/A$0.00N/A0.00N/AGap DownFMSFresenius Medical Care AG & Co. KGaA4.0537 of 5 stars$24.88-1.7%$27.80+11.8%+18.4%$0.00$20.63B20.391,384LFMDPLifeMDN/A$23.80-0.6%N/A+7.6%$0.00$245.56M0.00230Short Interest ↓OTRKPOntrakN/A$0.04+75.0%N/A-86.0%$0.00$10.84M0.00250Gap DownHigh Trading VolumePIIIWP3 Health PartnersN/A$0.01-19.3%N/AN/A$0.00$1.46B0.00500TALKWTalkspaceN/A$0.08+0.1%N/A+56.8%$0.00$202.61M0.00500Positive News Related Companies and Tools Related Companies UPHL Alternatives OPGN Alternatives ACONW Alternatives AONC Alternatives DHACW Alternatives FMS Alternatives LFMDP Alternatives OTRKP Alternatives PIIIW Alternatives TALKW Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BTTX) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredRetire Comfortably with These New Monthly Income ETFs?Too many retirees lie awake at night, worried their savings won’t last. Traditional advice and tiny returns ju...Investors Alley | SponsoredStrange crypto pattern discovered by 40-person research teamSomething unusual is happening inside a 40-person crypto research firm. They're helping 8,000+ ordinary peo...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BTTX Stock Alerts